Sign in to view content

Wet AMD 5 Symposium

Video
Published 2020

Related

Prophylaxis Intravitreal Aflibercept Against Conversion to Neovascular AMD in High-Risk Eyes (PRO-CON): 24-Month Results
Jeffrey S. Heier, MD
Annual Meeting Talks
2019
A Phase 1, Multicenter, Prospective, Open-Label, Dose Escalation Study of EYP-1901, a Tyrosine Kinase Inhibitor (TKI), in Subjects With Wet AMD
Vrinda S. Hershberger, MD, PhD
On Demand Cases, Courses, and Papers
2021
RAP Lesions
Thomas A. Ciulla, MD, MBA, FASRS
Retina Image Bank: Images of the Week
2014

Category: AMD-Neovascular

See more

Annual Meeting Talks